A carregar...
Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study
BACKGROUND: Sodium‐glucose linked transporter 2 inhibition recently emerged as a promising therapy for reducing the risk of heart failure (HF) in patients with type 2 diabetes mellitus (T2DM). However, there is a lack of data endorsing its role in symptomatic HF patients. We sought to evaluate the s...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489772/ https://ncbi.nlm.nih.gov/pubmed/29663436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22899 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|